U.S. Implantable Cardioverter Defibrillators Market Size & Outlook
U.S. implantable cardioverter defibrillators market, 2018-2030 (US$M)
Related Markets
U.S. implantable cardioverter defibrillators market highlights
- The U.S. implantable cardioverter defibrillators market generated a revenue of USD 1,361.8 million in 2023 and is expected to reach USD 1,988.9 million by 2030.
- The U.S. market is expected to grow at a CAGR of 5.6% from 2024 to 2030.
- In terms of segment, transvenous implantable cardioverter-defibrillators was the largest revenue generating product in 2023.
- Subcutaneous Implantable Cardioverter Defibrillators is the most lucrative product segment registering the fastest growth during the forecast period.
Implantable cardioverter defibrillators market data book summary
| Market revenue in 2023 | USD 1,361.8 million |
| Market revenue in 2030 | USD 1,988.9 million |
| Growth rate | 5.6% (CAGR from 2023 to 2030) |
| Largest segment | Transvenous implantable cardioverter-defibrillators |
| Fastest growing segment | Subcutaneous Implantable Cardioverter Defibrillators |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Transvenous Implantable Cardioverter-Defibrillators, Subcutaneous Implantable Cardioverter Defibrillators |
| Key market players worldwide | Abbott Laboratories, Medtronic PLC, BIOTRONIK, Boston Scientific Corp, MicroPort Scientific Corp, LivaNova PLC |
Other key industry trends
- In terms of revenue, U.S. accounted for 35.8% of the global implantable cardioverter defibrillators market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. implantable cardioverter defibrillators market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 326.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Implantable Cardioverter Defibrillators Market Scope
Implantable Cardioverter Defibrillators Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. implantable cardioverter defibrillators market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to implantable cardioverter defibrillators market will help companies and investors design strategic landscapes.
Transvenous implantable cardioverter-defibrillators was the largest segment with a revenue share of 89.87% in 2023. Horizon Databook has segmented the U.S. implantable cardioverter defibrillators market based on transvenous implantable cardioverter-defibrillators, subcutaneous implantable cardioverter defibrillators covering the revenue growth of each sub-segment from 2018 to 2030.
With the rise in the prevalence of Sudden Cardiac Arrests (SCA) in the U.S. and the high mortality associated with these diseases, the demand for ICDs is expected to rise. According to the Heart and Stroke Statistics 2022 by American Heart Association, over 356,000 out-of-hospital cardiac arrests are reported in the U.S. annually, and around 90% of them are fatal.
Furthermore, Health Savings Account (HSA) is a savings account for medical expenses, accessible to citizens of the U.S. who have enrolled in the High-Deductible Health Plan (HDHP). The difference between a Flexible Savings Account (FSA) and an HSA account is that funds can be accumulated in the HSA account.
The Health Reimbursement Arrangement (HRA) is a reimbursement scheme for employees with out-of-pocket medical expenditures. Furthermore, the growing preventive healthcare in the region by the implementation of screening initiatives such as Healthy People 2030 is expected to drive the market growth.
Reasons to subscribe to U.S. implantable cardioverter defibrillators market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. implantable cardioverter defibrillators market databook
-
Our clientele includes a mix of implantable cardioverter defibrillators market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. implantable cardioverter defibrillators market , including forecasts for subscribers. This country databook contains high-level insights into U.S. implantable cardioverter defibrillators market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. implantable cardioverter defibrillators market size, by product, 2018-2030 (US$M)
U.S. Implantable Cardioverter Defibrillators Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
